Defense Production Act (DPA) and COVID-19: Key Authorities and Policy Considerations [March 6, 2020] [open pdf - 685KB]
From the Document: "As the coronavirus (COVID-19) outbreak develops, the United States faces drug and medical supply scarcities due to disrupted supply chains and increased demand. In response, the President may exercise emergency authorities under the Defense Production Act of 1950 (DPA; 50 U.S.C. §§4501 et seq.) to address supply shortages and economic development impacts, and may have begun the process of doing so. This Insight considers DPA authorities that may be used to address domestic essential goods and materials shortages caused by the outbreak, and explores potential policy considerations for Congress. For more information on the health and epidemiological aspects of COVID-19, see CRS products R46219 and IF11421."
CRS Insight, IN11231
Congressional Research Service: https://crsreports.congress.gov/